We use cookies to provide you with a better experience. If you continue to use this site, we'll assume you're happy with this. Alternatively, click here to find out how to manage these cookies

hide cookie message
78,230 News Articles

AstraZeneca in confidential email blunder

Financial forecasts reissued after internal Excel spreadsheet sent to analysts

Pharmaceutical giant AstraZeneca has been forced to reissue its financial guidance after a major blunder saw it email confidential forecasts to analysts last week.

The company emailed a Microsoft Excel spreadsheet to the analysts, on which it had failed to delete internal data that was intended to remain confidential. Its next official financial update is in three weeks' time.

AstraZeneca was notified by one analyst that the spreadsheet contained internal data, it is understood. The company then sent a message asking others to destroy its email instead of reading it.

The internal predictions left on the spreadsheet date from late last year, revealing better figures than it announced in December after writedowns on some drug experiments.

In a statement to the markets, AstraZeneca said it supported the official figures released in December, which included guidance for earnings per share at "the lower half of the range of $7.20 to $7.40".


IDG UK Sites

OnePlus Two release date rumours: Something's happening on 22 July

IDG UK Sites

13in MacBook Air review, Apple's MacBook Air 2014 reviewed

IDG UK Sites

5 reasons to buy an electric car and 5 reasons not to

IDG UK Sites

Evernote Skitch: the best way for creatives to doodle feedback